Drosophila antimicrobial peptide mutants reveal unexpected roles in sleep and neural plasticity
Mutations in fly immune effectors known as antimicrobial peptides produce distinct effects on sleep duration and neuronal plasticity, independent of their defensive roles.
Research published in PLOS Genetics by Rahul Kumar, Gokul Madhav, Priyanka Balasubramanian and colleagues at institutions including those represented by co-authors Imroze Khan and Krishna Melnattur examines whether antimicrobial peptides (AMPs) — molecules central to innate immunity in Drosophila — also regulate sleep and synaptic plasticity when studied outside an infectious context.
In mammals, immune signalling molecules such as tumour necrosis factor-α and interleukin-1β are established sleep modulators. The parallel question in insects — whether the fly equivalents, the AMPs released systemically in response to infection, play analogous roles in neural function — had not been systematically addressed. The team generated and characterised mutants in a panel of distinct AMP genes and assessed sleep architecture and markers of neuronal plasticity.
Their results show that individual AMP mutations produced non-identical phenotypes: disrupting different AMPs altered sleep duration and plasticity in distinguishable ways, indicating that these molecules do not function as a redundant block but have separable neural roles. The findings extend the known biology of AMP molecules beyond host defence and add Drosophila to the growing list of model organisms in which immune and neural circuitry are functionally intertwined.
The work was conducted using established fly genetics approaches and is relevant to researchers studying sleep, neuroimmunology, and the pleiotropic functions of immune genes.
Sources
Read the original reporting — these are the public sources this summary draws from.
-
Primary source PLOS Genetics · 2026-11-13Mutations in antimicrobial peptides differently affect sleep and plasticity